Skip to main content
SpringerLink
Log in
Book cover

Biochemistry of Oxidative Stress pp 327–343Cite as

Mitochondrial DNA Damage in Autism

  • Chapter
  • First Online:

Part of the book series: Advances in Biochemistry in Health and Disease ((ABHD,volume 16))

Abstract

Mitochondria are organelles involved in essential roles in intermediary metabolism, perinatal neurodevelopment, immunity, bioenergetics, neurotransmitter metabolism, among other critical pathways. As such, mitochondrial dysfunction (MD) has deleterious effects with the potential of contributing to neurological diseases or enhancing their morbidity (e.g., autism and schizophrenia). Therefore, accumulation of mitochondrial damage is interpreted as a key element of the development of aging as well as neurodegenerative diseases. With the rise in the prevalence of autism spectrum disorders (ASD), there has been an increased interest in the etiology and contributors of this disorder. MD caused by genetics alone or by gene and environment interactions, may play a role in the etiology of ASD and holds promise for developing future therapies and/or interventions to help manage its symptoms or delaying its onset. Here we explore findings from our research and others analyzing the role of mitochondrial DNA damage as a contributor to ASD morbidity.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Giulivi C, Zhang YF, Omanska-Klusek A et al (2010) Mitochondrial dysfunction in autism. JAMA 304:2389–2396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Napoli E, Duenas N, Giulivi C (2014) Potential therapeutic use of the ketogenic diet in autism spectrum disorders. Front Pediatr 2:69

    Article  PubMed  PubMed Central  Google Scholar 

  3. Oliveira G, Diogo L, Grazina M et al (2005) Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47:185–189

    Article  CAS  PubMed  Google Scholar 

  4. Baio J (2012) Prevalence of autism spectrum disorders. Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61:1–19

    Google Scholar 

  5. Baio J (2014) Prevalence of autism spectrum disorder among children aged 8 years. Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. Morb Mortal Wkly Rep 63:1–21

    Google Scholar 

  6. Shelton JF, Hertz-Picciotto I, Pessah IN (2012) Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect 120:944–951

    Article  PubMed  PubMed Central  Google Scholar 

  7. Geier DA, Kern JK, Garver CR et al (2009) Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 280:101–108

    Article  CAS  PubMed  Google Scholar 

  8. Napoli E, Hung C, Wong S, Giulivi C (2013) Toxicity of the flame-retardant BDE-49 on brain mitochondria and neuronal progenitor striatal cells enhanced by a PTEN-deficient background. Toxicol Sci 132:196–210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hallmayer J, Cleveland S, Torres A et al (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68:1095–1102

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lord C, Risi S, Lambrecht L et al (2000) The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205–223

    Article  CAS  PubMed  Google Scholar 

  11. American Psychiatric Association (2000) American Psychiatric Association diagnostic and statistical manual of mental disorders, 4th edn, text revision. American Psychiatric Association, Washington, DC.

    Google Scholar 

  12. WHO (1992) International statistical classification of diseases and related health problems, vol 1, Tenth Revision. World Health Organization, Geneva.

    Google Scholar 

  13. Robin ED, Wong R (1988) Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol 136:507–513

    Article  CAS  PubMed  Google Scholar 

  14. Shay JW, Pierce DJ, Werbin H (1990) Mitochondrial DNA copy number is proportional to total cell DNA under a variety of growth conditions. J Biol Chem 265:14802–14807

    CAS  PubMed  Google Scholar 

  15. Lee HC, Yin PH, Lu CY et al (2000) Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J 348:425–432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Liu CS, Tsai CS, Kuo CL et al (2003) Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res 37:1307–1317

    Article  CAS  PubMed  Google Scholar 

  17. Chou YF, Huang RF (2009) Mitochondrial DNA deletions of blood lymphocytes as genetic markers of low folate-related mitochondrial genotoxicity in peripheral tissues. Eur J Nutr 48:429–436

    Article  CAS  PubMed  Google Scholar 

  18. Yeargin-Allsopp M, Rice C, Karapurkar T et al (2003) Prevalence of autism in a US metropolitan area. JAMA 289:49–55

    Article  PubMed  Google Scholar 

  19. Lee HC, Lu CY, Fahn HJ, Wei YH (1998) Aging- and smoking-associated alteration in the relative content of mitochondrial DNA in human lung. FEBS Lett 441:292–296

    Article  CAS  PubMed  Google Scholar 

  20. Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P et al (2006) Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38:1261–1268

    Article  CAS  PubMed  Google Scholar 

  21. Ylikallio E, Tyynismaa H, Tsutsui H et al (2010) High mitochondrial DNA copy number has detrimental effects in mice. Hum Mol Genet 19:2695–2705

    Article  CAS  PubMed  Google Scholar 

  22. Napoli E, Wong S, Giulivi C (2013) Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Mol Autism 4:2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Frustaci A, Neri M, Cesario A et al (2012) Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med 52:2128–2141

    Article  CAS  PubMed  Google Scholar 

  24. Rose S, Melnyk S, Trusty TA et al (2012) Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Res Treat 2012: :986519

    Google Scholar 

  25. Napoli E, Wong S, Hertz-Picciotto I, Giulivi C (2014) Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 133:1405–1410

    Article  Google Scholar 

  26. Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N (2011) Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 10:43–48

    Article  CAS  PubMed  Google Scholar 

  27. Chauhan A, Gu F, Essa MM et al (2011) Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 117:209–220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rose S, Melnyk S, Pavliv O et al (2012) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2:e134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Tang G, Gutierrez Rios P, Kuo SH et al (2013) Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis 54:349–361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. James SJ, Rose S, Melnyk S et al (2009) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. Faseb J 23:2374–2383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. James SJ, Cutler P, Melnyk S et al (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611–1617

    CAS  PubMed  Google Scholar 

  32. Theoharides TC, Asadi S, Patel AB (2013) Focal brain inflammation and autism. J Neuroinflammation 10:46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hertz-Picciotto I, Croen LA, Hansen R et al (2006) The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114:1119–1125

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wong S, Napoli E, Krakowiak P et al (2016) Role of p53, mitochondrial DNA deletions and paternal age in autism. Pediatrics e20151888

    Google Scholar 

  35. Graf WD, Marin-Garcia J, Gao HG et al (2000) Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol 15:357–361

    Article  CAS  PubMed  Google Scholar 

  36. Marin-Garcia J, Goldenthal MJ, Filiano JJ (2002) Cardiomyopathy associated with neurologic disorders and mitochondrial phenotype. J Child Neurol 17:759–765

    Article  PubMed  Google Scholar 

  37. Filipek PA, Juranek J, Smith M et al (2003) Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Annals Neurol 53:801–804

    Article  CAS  Google Scholar 

  38. Pons R, Andreu AL, Checcarelli N et al (2004) Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 144:81–85

    Article  CAS  PubMed  Google Scholar 

  39. Weissman JR, Kelley RI, Bauman ML et al (2008) Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One 3:e3815

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Shadel GS (2008) Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am J Pathol 172:1445–1456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Elliott HR, Samuels DC, Eden JA et al (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Schapira AHV Mitochondrial diseases. The Lancet 379:1825–1834

    Google Scholar 

  43. DiMauro S, Andreu AL (2001) Mutations in mitochondrial DNA as a cause of exercise intolerance. Ann Med 33:472–476

    Article  CAS  PubMed  Google Scholar 

  44. Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91:1922–1932

    Article  CAS  PubMed  Google Scholar 

  45. Zhou XP, Waite KA, Pilarski R et al (2003) Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73:404–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Delatycki MB, Danks A, Churchyard A et al (2003) De novo germline PTEN mutation in a man with Lhermitte-Duclos disease which arose on the paternal chromosome and was transmitted to his child with polydactyly and Wormian bones. J Med Genet 40:e92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Rickle A, Behbahani H, Ankarcrona M et al (2006) PTEN, Akt, and GSK3beta signalling in rat primary cortical neuronal cultures following tumor necrosis factor-alpha and trans-4-hydroxy-2-nonenal treatments. J Neurosci Res 84:596–605

    Article  CAS  PubMed  Google Scholar 

  48. Merks JH, de Vries LS, Zhou XP et al (2003) PTEN hamartoma tumour syndrome: variability of an entity. J Med Genet 40:e111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kerr F, Rickle A, Nayeem N et al (2006) PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Lett 580:3121–3128

    Article  CAS  PubMed  Google Scholar 

  50. Griffin RJ, Moloney A, Kelliher M et al (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer’s disease pathology. J Neurochem 93:105–117

    Article  CAS  PubMed  Google Scholar 

  51. Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22:183–198

    Article  CAS  PubMed  Google Scholar 

  52. Butler MG, Dasouki MJ, Zhou XP et al (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42:318–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Goffin A, Hoefsloot LH, Bosgoed E et al (2001) PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 105:521–524

    Article  CAS  PubMed  Google Scholar 

  54. Spinelli L, Black FM, Berg JN et al (2015) Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. J Med Genet 52:128–134

    Article  CAS  PubMed  Google Scholar 

  55. Clipperton-Allen AE, Page DT (2014) Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests. Hum Mol Genet 23:3490–3505

    Article  CAS  PubMed  Google Scholar 

  56. Zhou J, Parada LF (2012) PTEN signaling in autism spectrum disorders. Curr Opin Neurobiol 22:873–879

    Article  CAS  PubMed  Google Scholar 

  57. Kwon CH, Luikart BW, Powell CM et al (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377–388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Zhou J, Blundell J, Ogawa S et al (2009) Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 29:1773–1783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Napoli E, Ross-Inta C, Wong S et al (2012) Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One 7:e42504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Chaste P, Leboyer M (2012) Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci 14:281–292

    PubMed  PubMed Central  Google Scholar 

  61. Gill M (2012) Developmental psychopathology: the role of structural variation in the genome. Dev Psychopathol 24:1319–1334

    Article  PubMed  Google Scholar 

  62. McGrew SG, Peters BR, Crittendon JA, Veenstra-Vanderweele J (2012) Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement? J Autism Dev Disord 42:1582–1591

    Article  PubMed  Google Scholar 

  63. Miller DT, Shen Y, Wu BL (2012) Oligonucleotide microarrays for clinical diagnosis of copy number variation and zygosity status. Curr Protoc Hum Genet Chapter 8: Units 8–12

    Google Scholar 

  64. Lacaria M, Spencer C, Gu W et al (2012) Enriched rearing improves behavioral responses of an animal model for CNV-based autistic-like traits. Hum Mol Genet 21:3083–3096

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Moreno-Garcia M, Sanchez del Pozo J, Cruz-Rojo J et al (2012) Array-based characterization of an interstitial de novo deletion of chromosome 4q in a patient with a neuronal migration defect and hypocalcemia plus a literature review. Clin Dysmorphol 21:172–176

    Article  PubMed  Google Scholar 

  66. Philippe A (2012) Genetics of autism spectrum disorders. Medecine Therapeutique Pediatrie 15:194–201

    Google Scholar 

  67. Frye RE (2012) Mitochondrial disease in 22q13 duplication syndrome. J Child Neurol 27:942–949

    Article  PubMed  Google Scholar 

  68. Malenfant P, Liu X, Hudson ML et al (2012) Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders. J Autism Dev Disord 42:1459–1469

    Article  PubMed  Google Scholar 

  69. He WZ, Liu WQ, Zhong XQ et al (2012) Analysis of de novo copy number variations in a family affected with autism spectrum disorders using high-resolution array-based comparative genomic hybridization. Chinese J Med Genet 29:266–269

    CAS  Google Scholar 

  70. McDonald TA (2002) A perspective on the potential health risks of PBDEs. Chemosphere 46:745–755

    Article  CAS  PubMed  Google Scholar 

  71. Betts KS (2002) Rapidly rising PBDE levels in North America. Environ Sci Technol 36:50A–52A

    Article  CAS  PubMed  Google Scholar 

  72. Schecter A, Pavuk M, Papke O et al (2003) Polybrominated diphenyl ethers (PBDEs) in U.S. mothers’ milk. Environ Health Perspect 111:1723–1729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Petreas M, Nelson D, Brown FR et al (2011) High concentrations of polybrominated diphenylethers (PBDEs) in breast adipose tissue of California women. Environ Int 37:190–197

    Article  CAS  PubMed  Google Scholar 

  74. Bernier FP, Boneh A, Dennett X et al (2002) Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1406–1411

    Article  CAS  PubMed  Google Scholar 

  75. Giulivi C, Napoli E, Schwartzer J et al (2013) Gestational exposure to a viral mimetic poly(i:C) results in long-lasting changes in mitochondrial function by leucocytes in the adult offspring. Mediators Inflamm 2013:602–609

    Article  CAS  Google Scholar 

  76. Alexander FE, Patheal SL, Biondi A et al (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61:2542–2546

    CAS  PubMed  Google Scholar 

  77. Ma X, Buffler PA, Gunier RB et al (2002) Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 110:955–960

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Woodruff TJ, Axelrad DA, Kyle AD et al (2004) Trends in environmentally related childhood illnesses. Pediatrics 113:1133–1140

    PubMed  Google Scholar 

  79. Kim KH, Bose DD, Ghogha A et al (2011) Para- and ortho-substitutions are key determinants of polybrominated diphenyl ether activity toward ryanodine receptors and neurotoxicity. Environ Health Perspect 119:519–526

    Article  CAS  PubMed  Google Scholar 

  80. Dingemans MM, van den Berg M, Westerink RH (2011) Neurotoxicity of brominated flame retardants. (In) direct effects of parent and hydroxylated polybrominated diphenyl ethers on the (developing) nervous system. Environ Health Perspect 119:900–907

    Google Scholar 

  81. Belmonte MK, Bourgeron T (2006) Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 9:1221–1225

    Article  CAS  PubMed  Google Scholar 

  82. Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26:383–392

    Article  CAS  PubMed  Google Scholar 

  83. Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280

    Article  PubMed  PubMed Central  Google Scholar 

  84. Brown AS, Patterson PH (2011) Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 37:284–290

    Article  PubMed  Google Scholar 

  85. Patterson PH (2011) Maternal infection and immune involvement in autism. Trends Mol Med 17:389–394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Patterson PH (2012) Maternal infection and autism. Brain Behav Immun 26:393

    Article  PubMed  Google Scholar 

  87. Brown AS, Begg MD, Gravenstein S et al (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774–780

    Article  PubMed  Google Scholar 

  88. Brown AS, Hooton J, Schaefer CA et al (2004) Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161:889–895

    Article  PubMed  Google Scholar 

  89. Atladottir HO, Thorsen P, Ostergaard L et al (2010) Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40:1423–1430

    Article  PubMed  Google Scholar 

  90. Tinsley JH, Chiasson VL, Mahajan A et al (2009) Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am J Hypertens 22:1314–1319

    Article  CAS  PubMed  Google Scholar 

  91. Chatterjee P, Chiasson VL, Kopriva SE et al (2011) Interleukin 10 deficiency exacerbates toll-like receptor 3-induced preeclampsia-like symptoms in mice. Hypertension 58:489–496

    Article  CAS  PubMed  Google Scholar 

  92. Cipolla MJ, Houston EM, Kraig RP, Bonney EA (2011) Differential effects of low-dose endotoxin on the cerebral circulation during pregnancy. Reprod Sci 18:1211–1221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Abrahams VM, Bole-Aldo P, Kim YM et al (2004) Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 173:4286–4296

    Article  CAS  PubMed  Google Scholar 

  94. Pineda A, Verdin-Teran SL, Camacho A, Moreno-Fierros L (2011) Expression of toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch Med Res 42:382–391

    Article  CAS  PubMed  Google Scholar 

  95. Walker CK, Anderson KW, Milano KM et al (2013) Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism. Biol Psychiatry 74:204–211

    Article  PubMed  PubMed Central  Google Scholar 

  96. West AP, Shadel GS, Ghosh S (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11:389–402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Arnoult D, Soares F, Tattoli I, Girardin SE (2011) Mitochondria in innate immunity. EMBO Rep 12:901–910

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Cloonan SM, Choi AM (2012) Mitochondria: commanders of innate immunity and disease? Curr Opin Immunol 24:32–40

    Article  CAS  PubMed  Google Scholar 

  99. Fossati G, Moulding DA, Spiller DG et al (2003) The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 170:1964–1972

    Article  CAS  PubMed  Google Scholar 

  100. Genestier AL, Michallet MC, Prevost G et al (2005) Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115:3117–3127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Scheel-Toellner D, Wang K, Craddock R et al (2004) Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 104:2557–2564

    Article  CAS  PubMed  Google Scholar 

  102. Maianski NA, Roos D, Kuijpers TW (2003) Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 101:1987–1995

    Article  CAS  PubMed  Google Scholar 

  103. Burgueno AL, Cabrerizo R, Gonzales-Mansilla N et al (2013) Maternal high-fat intake during pregnancy programs metabolic-syndrome-related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPAR-GC1A. J Nutr Biochem 24:6–13

    Article  CAS  PubMed  Google Scholar 

  104. Garcia AP, Priego T, Palou M et al (2013) Early alterations in plasma ghrelin levels in offspring of calorie-restricted rats during gestation may be linked to lower sympathetic drive to the stomach. Peptides 39:59–63

    Article  CAS  PubMed  Google Scholar 

  105. Garay PA, Hsiao EY, Patterson PH, McAllister AK (2013) Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 31:54–68

    Article  CAS  PubMed  Google Scholar 

  106. Freeman J, Veggiotti P, Lanzi G et al (2006) The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 68:145–180

    Article  CAS  PubMed  Google Scholar 

  107. Halestrap AP (2013) Monocarboxylic acid transport. Compr Physiol 3:1611–1643

    Article  PubMed  Google Scholar 

  108. Olpin SE (2004) Implications of impaired ketogenesis in fatty acid oxidation disorders. Prostagl Leukot Essent Fatty Acids 70:293–308

    Article  CAS  Google Scholar 

  109. Hartman AL, Gasior M, Vining EP, Rogawski MA (2007) The neuropharmacology of the ketogenic diet. Pediatr Neurol 36:281–292

    Article  PubMed  PubMed Central  Google Scholar 

  110. Kossoff EH, Wang HS (2013) Dietary therapies for epilepsy. Biomed J 36:2–8

    Article  PubMed  Google Scholar 

  111. Marsh EB, Freeman JM, Kossoff EH et al (2006) The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. Epilepsia 47:425–430

    Article  PubMed  Google Scholar 

  112. Rogovik AL, Goldman RD (2010) Ketogenic diet for treatment of epilepsy. Can Fam Physician 56:540–542

    PubMed  PubMed Central  Google Scholar 

  113. Coppola G, Verrotti A, Ammendola E et al (2010) Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur J Paediatr Neurol 14:229–234

    Article  PubMed  Google Scholar 

  114. El-Gharbawy AH, Boney A, Young SP, Kishnani PS (2011) Follow-up of a child with pyruvate dehydrogenase deficiency on a less restrictive ketogenic diet. Mol Genet Metab 102:214–215

    Article  CAS  PubMed  Google Scholar 

  115. Baranano KW, Hartman AL (2008) The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol 10:410–419

    Article  PubMed  PubMed Central  Google Scholar 

  116. Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3:59

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  117. Evangeliou A, Vlachonikolis I, Mihailidou H et al (2003) Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol 18:113–118

    Article  PubMed  Google Scholar 

  118. Herbert MR, Buckley JA (2013) Autism and dietary therapy: case report and review of the literature. J Child Neurol 28:975–982

    Article  PubMed  Google Scholar 

  119. Ahola-Erkkila S, Carroll CJ, Peltola-Mjosund K et al (2010) Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet 19:1974–1984

    Article  CAS  PubMed  Google Scholar 

  120. Bough KJ, Wetherington J, Hassel B et al (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60:223–235

    Article  CAS  PubMed  Google Scholar 

  121. Hughes SD, Kanabus M, Anderson G et al (2014) The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells. J Neurochem 129:426–433

    Article  CAS  PubMed  Google Scholar 

  122. Tachibana M, Sparman M, Sritanaudomchai H et al (2009) Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461:367–372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. DiMauro S, Hirano M, Schon EA (2006) Approaches to the treatment of mitochondrial diseases. Muscle Nerve 34:265–283

    Article  CAS  PubMed  Google Scholar 

  124. Kerr DS (2010) Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Mol Genet Metab 99:246–255

    Article  CAS  PubMed  Google Scholar 

  125. Schon EA, DiMauro S, Hirano M, Gilkerson RW (2010) Therapeutic prospects for mitochondrial disease. Trends Mol Med 16:268–276

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Wenz T, Diaz F, Spiegelman BM, Moraes CT (2008) Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8:249–256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Mootha VK, Handschin C, Arlow D et al (2004) Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A 101:6570–6575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Wenz T, Rossi SG, Rotundo RL et al (2009) Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A 106:20405–20410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Ikeuchi M, Matsusaka H, Kang D et al (2005) Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation 112:683–690

    Article  CAS  PubMed  Google Scholar 

  130. Marriage BJ, Clandinin MT, Macdonald IM, Glerum DM (2004) Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol Genet Metab 81:263–272

    Article  CAS  PubMed  Google Scholar 

  131. Urnov FD, Rebar EJ (2002) Designed transcription factors as tools for therapeutics and functional genomics. Biochem Pharmacol 64:919–923

    Article  CAS  PubMed  Google Scholar 

  132. Porteus MH, Carroll D (2005) Gene targeting using zinc finger nucleases. Nat Biotechnol 23:967–973

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the families that participated in this study as well as the technical and intellectual contributions over the years of Catherine Ross-Inta, Alicja Omanska-Klusek, Gyu Song, Yi-Fan Zhang, Daniel Sakaguchi, Casey Bronec, Erica Santos, Nadia Dueñas, Joel Ramirez, Prithvi Bomdica, Allegra De Sandri, and Drs. Eleonora Napoli, Siming Liu, Kazu Kato and Yasuko Fujisawa. We are grateful for the scientific collaborations with Drs. Irva Hertz-Picciotto, Sally Ozonoff, Randi Hagerman, and Flora Tassone that made these studies possible. The research in this article was supported by grants from the Simons Foundation (SFARI 271406) and National Institute of Environmental Health Sciences R01-ES011269, R01-ES015359, R01-ES020392, and P30-ES023513. The National Institute of Child and Human Development: U45-HD079125; EPA Science to Achieve Results (STAR): R-829388 and R833292; and the University of California Davis MIND Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, 95616, USA

    Sarah Rose, Sarah Wong & Cecilia Giulivi

  2. Medical Investigations of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, Sacramento, CA, 95817, USA

    Cecilia Giulivi

Authors
  1. Sarah Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cecilia Giulivi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cecilia Giulivi .

Editor information

Editors and Affiliations

  1. School of Medicine, University of Buenos Aires, Buenos Aires, Argentina

    Ricardo Jorge Gelpi

  2. School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina

    Alberto Boveris

  3. Instituto de Inmunología, Genética y Metabolismo (INIGEM, UBA–CONICET), Laboratorio de Metabolismo del Oxígeno, Hospital Universitario, Universidad de Buenos Aires, Buenos Aires, Argentina

    Juan José Poderoso

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rose, S., Wong, S., Giulivi, C. (2016). Mitochondrial DNA Damage in Autism. In: Gelpi, R., Boveris, A., Poderoso, J. (eds) Biochemistry of Oxidative Stress. Advances in Biochemistry in Health and Disease, vol 16. Springer, Cham. https://doi.org/10.1007/978-3-319-45865-6_21

Download citation

Publish with us

Policies and ethics

Search

Navigation